...
首页> 外文期刊>Acta oncologica. >Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group.
【24h】

Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group.

机译:乳腺癌治疗后的怀孕-代表丹麦乳腺癌合作组织进行的一项基于人群的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Estrogen is an established growth factor in breast cancer and it has been hypothesized that pregnancy associated estrogens may increase the risk of recurrence of breast cancer. In 1997 we published a population-based Danish study indicating no negative prognostic effect of pregnancy after breast cancer treatment. The present study is a ten-year update. MATERIAL AND METHODS: Danish Breast Cancer Cooperative Group has since 1977 collected population-based data on tumour characteristics, treatment regimes, and follow-up status on Danish women with breast cancer. Pregnancy history was added from the Danish Civil Registration System, the National Birth Registry, and the National Induced Abortion registry. Cox regression was used to estimate the risk ratio of dying among women with a pregnancy after breast cancer treatment compared with women without such experience. RESULTS: In all, 10 236 women with primary breast cancer aged 45 years or less at the time of diagnosis were followed for 95 616 person years. Among these, 371 women experienced pregnancy after treatment of breast cancer. In a multivariate analysis that included age at diagnosis, stage of disease, and pregnancy history prior to diagnosis, women who had a full-term pregnancy subsequent to breast cancer treatment were found to have a reduced risk of dying (relative risk: 0.73; 95% confidence interval: 0.54-0.99) compared with other women with breast cancer. The effect was not significantly modified by age at diagnosis, tumour size, nodal status, or pregnancy history before diagnosis of breast cancer. Neither spontaneous abortions nor induced abortions subsequent to breast cancer treatment had a negative impact on prognosis. CONCLUSION: In line with our previous study, but based on more than twice the patient material, we found no evidence that a pregnancy after treatment of breast cancer has a negative influence the prognosis.
机译:背景:雌激素是乳腺癌中已确立的生长因子,据推测与妊娠相关的雌激素可能会增加乳腺癌复发的风险。 1997年,我们发表了一项基于人群的丹麦研究,该研究表明在乳腺癌治疗后,怀孕没有负面的预后效果。本研究是十年更新。材料与方法:丹麦乳腺癌合作组织自1977年以来一直收集有关丹麦乳腺癌女性的肿瘤特征,治疗方案和随访情况的人群数据。从丹麦的民事登记系统,国家出生登记处和国家人工流产登记处增加了怀孕史。使用Cox回归来估计在接受乳腺癌治疗后怀孕的妇女与没有这种经验的妇女相比死亡的风险比。结果:总共对10 236名在诊断时年龄在45岁以下的原发性乳腺癌妇女进行了95 616人年的随访。其中,有371名妇女在接受乳腺癌治疗后怀孕。在一项多变量分析中,包括诊断时的年龄,疾病的阶段以及诊断之前的妊娠史,发现接受乳腺癌治疗后足月妊娠的妇女死亡风险降低(相对危险度:0.73; 95)。 %置信区间:0.54-0.99),与其他乳腺癌女性相比。在诊断乳腺癌之前,诊断时的年龄,肿瘤大小,淋巴结状态或妊娠史并未明显改变疗效。乳腺癌治疗后的自然流产和人工流产均未对预后产生负面影响。结论:与我们先前的研究一致,但基于两倍以上的患者资料,我们没有发现证据表明乳腺癌治疗后怀孕对预后有负面影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号